Kaleido UK launch

At the end of April ViCentra announced the UK launch of its Kaleido insulin pump system, which it says is the smallest, lightest and most

Read More »

New oral drug for T1D

The European Commission (EC) has approved Forxiga (dapagliflozin) for use in Type 1 diabetes (T1D) as an adjunct to insulin in patients with a BMI

Read More »

Cellnovo Ltd (UK) ceases production

The administrators appointed at Cellnovo Ltd., the Cellnovo Group (“Cellnovo” or the “Company”)’s UK subsidiary, have concluded an initial analysis and have actioned a restructuring

Read More »